Code | 9825C | ||||||||||
MA number | 44/0393/18-S | ||||||||||
Product Form: | tbl flm 60x50 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 12.12.2018 |
SPC: | SPC_Dasatinib Sandoz 50 mg_09.2023.pdf |
PIL: | PIL_Dasatinib Sandoz 50 mg_09.2023.pdf |
Safety feature | Yes |
Data update: | 06.09.2023 |